This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gandhi, M. Articles by Greenblatt, R.M. Search for Related Content PubMed PubMed Citation Articles by Gandhi, M. Articles by Greenblatt, R.M. Social Bookmarking                         What's this?

Prevalence of Human Herpesvirus-8 Salivary Shedding in HIV Increases with CD4 Count

¹ University of California, San Francisco (UCSF), 405 Irving Street, 2nd floor, San Francisco, CA 94122, USA;
² School of Medicine, University of Washington, Seattle, USA;
³ School of Medicine, University of California, San Francisco, USA;
⁴ School of Dentistry, University of California, San Francisco, USA;
⁵ School of Dentistry, University of Southern California, Los Angeles, USA; and
⁶ Lincoln Medical & Mental Health Center, Bronx, NY, USA;

Correspondence: ^* corresponding author, mgandhi{at}itsa.ucsf.edu

Human herpesvirus-8 (HHV-8) is the etiologic agent of Kaposi’s sarcoma (KS), which occurs in epidemic form in human immunodeficiency virus(HIV)-infected individuals. Saliva is the only mucosal fluid in which infectious HHV-8 has been identified, although factors associated with HHV-8 salivary shedding remain unclear. Our study performed PCR analysis for HHV-8 DNA in saliva (and other body fluids) in 66 HIV- and HHV-8-co-infected women without KS so that we could examine predictors for HHV-8 DNA detection. CD4 count was the most significant predictor of HHV-8 salivary shedding, with increased prevalence of HHV-8 salivary DNA at higher CD4 counts. The odds of salivary HHV8 shedding at CD4 counts > = 350 cells/µL was 63 times the odds of shedding at CD4 < 350 (95%CI, 1.3–3078), with an increase in effect size when the analysis was restricted to those with a CD4 nadir > 200. Analysis of these data suggests an increased potential for HHV-8 transmission early in HIV infection, with implications for HHV-8 prevention.

Key Words: HHV-8 • Kaposi’s sarcoma • HIV • salivary shedding • CD4 count

Journal of Dental Research, Vol. 83, No. 8, 639-643 (2004)
DOI: 10.1177/154405910408300811


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. S. Miller, J. R. Berger, Y. Mootoor, S. A. Avdiushko, H. Zhu, and R. J. Kryscio High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J. Clin. Microbiol., July 1, 2006; 44(7): 2409 - 2415. [Abstract] [Full Text] [PDF]

				C.G. Teo Conceptual Emergence of Human Herpesvirus 8 (Kaposi's Sarcoma-associated Herpesvirus) as an Oral Herpesvirus Advances in Dental Research, April 1, 2006; 19(1): 85 - 90. [Abstract] [Full Text] [PDF]